ID

30215

Descripción

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy; ODM derived from: https://clinicaltrials.gov/show/NCT00891137

Link

https://clinicaltrials.gov/show/NCT00891137

Palabras clave

Versiones (1)
  1. 19/5/18 19/5/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

19 de mayo de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Leukemia NCT00891137

Inglés

Eligibility Leukemia NCT00891137

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00891137
Criteria
Descripción

Criteria

undergoing allogeneic (4-6/6 matched) umbilical cord blood graft with at least 2.5 x 10e7 cells/kg for hematological malignancy:
Descripción

Umbilical Cord Blood Graft allogeneic | Cells per Kilogram Quantity Hematologic Neoplasms

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0162371
UMLS CUI [1,2]
C1961139
UMLS CUI [1,3]
C1515895
UMLS CUI [2,1]
C3899697
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0376545
high risk acute myeloid leukemia (aml) in complete remission
Descripción

AML High risk In complete remission

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C0332167
UMLS CUI [1,3]
C0677874
very high risk pediatric aml; patients <21 years eligible with <25% blasts in marrow after failed chemotherapy
Descripción

Pediatric acute myeloblastic leukemia High risk Very | Age | Blasts Bone marrow Percentage | Status post Chemotherapy failed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0220621
UMLS CUI [1,2]
C0332167
UMLS CUI [1,3]
C0442824
UMLS CUI [2]
C0001779
UMLS CUI [3,1]
C1982687
UMLS CUI [3,2]
C0439165
UMLS CUI [4,1]
C0231290
UMLS CUI [4,2]
C0392920
UMLS CUI [4,3]
C0231175
high risk acute lymphocytic leukemia (all) in complete remission
Descripción

Acute lymphocytic leukemia High risk In complete remission

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023449
UMLS CUI [1,2]
C0332167
UMLS CUI [1,3]
C0677874
chronic myelogenous leukemia (cml), excluding refractory blast crisis
Descripción

Myeloid Leukemia, Chronic | Blast Phase refractory Excluded

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023473
UMLS CUI [2,1]
C0005699
UMLS CUI [2,2]
C0205269
UMLS CUI [2,3]
C0332196
myelodysplasia (mds) ipps int-2 or high risk, or refractory anemia with severe pancytopenia or high risk cytogenetics
Descripción

Myelodysplasia IPSS | Refractory anemias | Pancytopenia Severe | Cytogenetic Analysis High risk

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0026985
UMLS CUI [1,2]
C2827405
UMLS CUI [2]
C0002893
UMLS CUI [3,1]
C0030312
UMLS CUI [3,2]
C0205082
UMLS CUI [4,1]
C0752095
UMLS CUI [4,2]
C0332167
chronic lymphocytic leukemia (cll), small lymphocytic lymphoma (sll), marginal zone b-cell lymphoma or follicular lymphoma that have progressed after two prior therapies
Descripción

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Marginal Zone B-Cell Lymphoma | Follicular Lymphoma progressed | Status post Prior Therapy Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023434
UMLS CUI [2]
C0855095
UMLS CUI [3]
C1367654
UMLS CUI [4,1]
C0024301
UMLS CUI [4,2]
C1272688
UMLS CUI [5,1]
C0231290
UMLS CUI [5,2]
C1514463
UMLS CUI [5,3]
C1265611
lymphoplasmacytic, lymphoma, mantle-cell lymphoma, prolymphocytic leukemia after initial therapy and complete or partial remission
Descripción

Lymphoplasmacytic lymphoma | Mantle-cell lymphoma | Prolymphocytic Leukemia | Status post Therapeutic procedure Initial | Status post Complete remission | Status post Partial response

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024419
UMLS CUI [2]
C0334634
UMLS CUI [3]
C0023486
UMLS CUI [4,1]
C0231290
UMLS CUI [4,2]
C0087111
UMLS CUI [4,3]
C0205265
UMLS CUI [5,1]
C0231290
UMLS CUI [5,2]
C0677874
UMLS CUI [6,1]
C0231290
UMLS CUI [6,2]
C1521726
large cell non-hodgkin lymphoma (nhl) in second complete or partial remission (chemotherapy refractory large cell nhl not eligible)
Descripción

Non-Hodgkin Lymphoma Large Cell | Complete remission second | Partial response

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0024305
UMLS CUI [1,2]
C1513997
UMLS CUI [2,1]
C0677874
UMLS CUI [2,2]
C0205436
UMLS CUI [3]
C1521726
lymphoblastic lymphoma, peripheral t cell lymphoma including angioimmunoblastic lymphoma, burkitt's lymphoma, and other high-grade nhl after initial therapy if stage iii/iv in complete or partial remission, or after progression if stage i/ii <1 year (chemotherapy refractory high-grade nhl not eligible)
Descripción

Lymphoblastic lymphoma | Peripheral T-Cell Lymphoma | Angioimmunoblastic Lymphoma | Burkitt Lymphoma | Non-Hodgkin Lymphoma High grade | Status post Therapeutic procedure Initial | Ann Arbor lymphoma staging system Complete remission | Ann Arbor lymphoma staging system Partial response | Ann Arbor lymphoma staging system Post Disease Progression

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079748
UMLS CUI [2]
C0079774
UMLS CUI [3]
C0020981
UMLS CUI [4]
C0006413
UMLS CUI [5,1]
C0024305
UMLS CUI [5,2]
C1962917
UMLS CUI [6,1]
C0231290
UMLS CUI [6,2]
C0087111
UMLS CUI [6,3]
C0205265
UMLS CUI [7,1]
C0432516
UMLS CUI [7,2]
C0677874
UMLS CUI [8,1]
C0432516
UMLS CUI [8,2]
C1521726
UMLS CUI [9,1]
C0432516
UMLS CUI [9,2]
C0687676
UMLS CUI [9,3]
C0242656
multiple myeloma beyond 2nd partial remission
Descripción

Multiple Myeloma | Exception Partial response second

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0026764
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1521726
UMLS CUI [2,3]
C0205436
preparative regimen consisting of cyclophosphamide, fludarabine, and total body irradiation
Descripción

Preparative Regimen | Cyclophosphamide | fludarabine | Whole-Body Irradiation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1882454
UMLS CUI [2]
C0010583
UMLS CUI [3]
C0059985
UMLS CUI [4]
C0043162
adequate organ function
Descripción

Organ function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678852
key exclusion criteria:
Descripción

Exclusion Criteria Main

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
symptomatic underlying pulmonary disease or requiring oxygen
Descripción

Lung disease Symptomatic | Requirement Oxygen

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0024115
UMLS CUI [1,2]
C0231220
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C0030054
active infection
Descripción

Communicable Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
hiv positive
Descripción

HIV Seropositivity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019699
pregnant or nursing
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Volver a la parte superior de la página

Similar models

Eligibility Leukemia NCT00891137

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00891137
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Umbilical Cord Blood Graft allogeneic | Cells per Kilogram Quantity Hematologic Neoplasms
Item
undergoing allogeneic (4-6/6 matched) umbilical cord blood graft with at least 2.5 x 10e7 cells/kg for hematological malignancy:
boolean
C0162371 (UMLS CUI [1,1])
C1961139 (UMLS CUI [1,2])
C1515895 (UMLS CUI [1,3])
C3899697 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0376545 (UMLS CUI [2,3])
AML High risk In complete remission
Item
high risk acute myeloid leukemia (aml) in complete remission
boolean
C0023467 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
C0677874 (UMLS CUI [1,3])
Pediatric acute myeloblastic leukemia High risk Very | Age | Blasts Bone marrow Percentage | Status post Chemotherapy failed
Item
very high risk pediatric aml; patients <21 years eligible with <25% blasts in marrow after failed chemotherapy
boolean
C0220621 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
C0442824 (UMLS CUI [1,3])
C0001779 (UMLS CUI [2])
C1982687 (UMLS CUI [3,1])
C0439165 (UMLS CUI [3,2])
C0231290 (UMLS CUI [4,1])
C0392920 (UMLS CUI [4,2])
C0231175 (UMLS CUI [4,3])
Acute lymphocytic leukemia High risk In complete remission
Item
high risk acute lymphocytic leukemia (all) in complete remission
boolean
C0023449 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
C0677874 (UMLS CUI [1,3])
Myeloid Leukemia, Chronic | Blast Phase refractory Excluded
Item
chronic myelogenous leukemia (cml), excluding refractory blast crisis
boolean
C0023473 (UMLS CUI [1])
C0005699 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
C0332196 (UMLS CUI [2,3])
Myelodysplasia IPSS | Refractory anemias | Pancytopenia Severe | Cytogenetic Analysis High risk
Item
myelodysplasia (mds) ipps int-2 or high risk, or refractory anemia with severe pancytopenia or high risk cytogenetics
boolean
C0026985 (UMLS CUI [1,1])
C2827405 (UMLS CUI [1,2])
C0002893 (UMLS CUI [2])
C0030312 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0752095 (UMLS CUI [4,1])
C0332167 (UMLS CUI [4,2])
Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Marginal Zone B-Cell Lymphoma | Follicular Lymphoma progressed | Status post Prior Therapy Quantity
Item
chronic lymphocytic leukemia (cll), small lymphocytic lymphoma (sll), marginal zone b-cell lymphoma or follicular lymphoma that have progressed after two prior therapies
boolean
C0023434 (UMLS CUI [1])
C0855095 (UMLS CUI [2])
C1367654 (UMLS CUI [3])
C0024301 (UMLS CUI [4,1])
C1272688 (UMLS CUI [4,2])
C0231290 (UMLS CUI [5,1])
C1514463 (UMLS CUI [5,2])
C1265611 (UMLS CUI [5,3])
Lymphoplasmacytic lymphoma | Mantle-cell lymphoma | Prolymphocytic Leukemia | Status post Therapeutic procedure Initial | Status post Complete remission | Status post Partial response
Item
lymphoplasmacytic, lymphoma, mantle-cell lymphoma, prolymphocytic leukemia after initial therapy and complete or partial remission
boolean
C0024419 (UMLS CUI [1])
C0334634 (UMLS CUI [2])
C0023486 (UMLS CUI [3])
C0231290 (UMLS CUI [4,1])
C0087111 (UMLS CUI [4,2])
C0205265 (UMLS CUI [4,3])
C0231290 (UMLS CUI [5,1])
C0677874 (UMLS CUI [5,2])
C0231290 (UMLS CUI [6,1])
C1521726 (UMLS CUI [6,2])
Non-Hodgkin Lymphoma Large Cell | Complete remission second | Partial response
Item
large cell non-hodgkin lymphoma (nhl) in second complete or partial remission (chemotherapy refractory large cell nhl not eligible)
boolean
C0024305 (UMLS CUI [1,1])
C1513997 (UMLS CUI [1,2])
C0677874 (UMLS CUI [2,1])
C0205436 (UMLS CUI [2,2])
C1521726 (UMLS CUI [3])
Lymphoblastic lymphoma | Peripheral T-Cell Lymphoma | Angioimmunoblastic Lymphoma | Burkitt Lymphoma | Non-Hodgkin Lymphoma High grade | Status post Therapeutic procedure Initial | Ann Arbor lymphoma staging system Complete remission | Ann Arbor lymphoma staging system Partial response | Ann Arbor lymphoma staging system Post Disease Progression
Item
lymphoblastic lymphoma, peripheral t cell lymphoma including angioimmunoblastic lymphoma, burkitt's lymphoma, and other high-grade nhl after initial therapy if stage iii/iv in complete or partial remission, or after progression if stage i/ii <1 year (chemotherapy refractory high-grade nhl not eligible)
boolean
C0079748 (UMLS CUI [1])
C0079774 (UMLS CUI [2])
C0020981 (UMLS CUI [3])
C0006413 (UMLS CUI [4])
C0024305 (UMLS CUI [5,1])
C1962917 (UMLS CUI [5,2])
C0231290 (UMLS CUI [6,1])
C0087111 (UMLS CUI [6,2])
C0205265 (UMLS CUI [6,3])
C0432516 (UMLS CUI [7,1])
C0677874 (UMLS CUI [7,2])
C0432516 (UMLS CUI [8,1])
C1521726 (UMLS CUI [8,2])
C0432516 (UMLS CUI [9,1])
C0687676 (UMLS CUI [9,2])
C0242656 (UMLS CUI [9,3])
Multiple Myeloma | Exception Partial response second
Item
multiple myeloma beyond 2nd partial remission
boolean
C0026764 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1521726 (UMLS CUI [2,2])
C0205436 (UMLS CUI [2,3])
Preparative Regimen | Cyclophosphamide | fludarabine | Whole-Body Irradiation
Item
preparative regimen consisting of cyclophosphamide, fludarabine, and total body irradiation
boolean
C1882454 (UMLS CUI [1])
C0010583 (UMLS CUI [2])
C0059985 (UMLS CUI [3])
C0043162 (UMLS CUI [4])
Organ function
Item
adequate organ function
boolean
C0678852 (UMLS CUI [1])
Exclusion Criteria Main
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Lung disease Symptomatic | Requirement Oxygen
Item
symptomatic underlying pulmonary disease or requiring oxygen
boolean
C0024115 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C1514873 (UMLS CUI [2,1])
C0030054 (UMLS CUI [2,2])
Communicable Disease
Item
active infection
boolean
C0009450 (UMLS CUI [1])
HIV Seropositivity
Item
hiv positive
boolean
C0019699 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial